Spirometric values associated with clinical form and risk of death and stroke in chagasic patients

Biomed Rep. 2022 Sep 15;17(5):88. doi: 10.3892/br.2022.1571. eCollection 2022 Nov.

Abstract

The aim of the present study was to compare pulmonary function among patients with different clinical forms and scores for risk of death and stroke. Patients were recruited from the Chagas Disease Ambulatory Service at the University of Rio Grande do Norte State (Mossoró, Brazil). The evaluation of pulmonary function was performed through spirometry techniques using a digital spirometer, and information about the clinical forms (cardiac, cardiodigestive, digestive and undetermined) and scores for risk of death (Rassi's risk-of-death score) and stroke was subsequently collected. Upon completion of the evaluation, comparisons of the values obtained between the groups for different clinical forms, risk stratification of stroke and Rassi's risk-of-death were made. The study cohort consisted of 72 patients. Individuals with a low risk of death had significantly higher values in the Tiffeneau index and individuals with a low risk of stroke presented with higher percentage values for forced vital capacity and forced expiratory volume in 1 sec. In addition, individuals with heart disease had worse percentage values for FVC and FEV1. In conclusion, the results showed that spirometry was an effective analytical technique and was associated with clinical forms, and death and stroke risk scores, in patients with Chagas disease, adding an important prognostic tool to those currently available.

Keywords: chagas cardiomyopathy; chagas disease; prognosis; pulmonary function test; spirometry.

Grants and funding

Funding: This research was funded in part by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brazil (grant no. 001).